top of page

National Polling On PBM and Drug Cost Issues

Jun 7, 2024

The National Community Pharmacists Association (NCPA) conducted a public poll of 1,000 Americans
highlighting significant public concern regarding prescription drug costs and the role of Pharmacy Benefit
Managers (PBMs) in drug pricing...

The National Community Pharmacists Association (NCPA) conducted a public poll of 1,000 Americans highlighting significant public concern regarding prescription drug costs and the role of Pharmacy Benefit Managers (PBMs) in drug pricing. Key findings include:


High Prescription Drug Costs: An overwhelming 84% of respondents agree that prescription drug costs are too high, indicating a widespread consensus on this issue.

Concern Over PBMs: 73% of those surveyed express concern about the impact of PBMs on drug pricing, suggesting that the public perceives PBMs as a significant factor in rising drug costs.

Perceived Role of PBMs in Increasing Costs: 68% agree that PBMs are driving up drug costs, reflecting a strong belief that these intermediaries are contributing to higher prescription prices.

Support for Legislative Action: 60% of respondents would be more likely to vote for a candidate who supports legislation aimed at addressing PBM abuses, showing a clear preference for political action to tackle this issue.

Call for Oversight: 62% support congressional oversight of PBM practices to ensure fair pricing and transparency, underscoring a demand for regulatory measures to monitor and potentially reform PBM operations. These findings suggest a broad and deep concern among the public regarding prescription drug affordability and the role of PBMs, with substantial support for legislative and regulatory interventions to address these issues.


The full poll is contained in this report.

https://ncpa.org/sites/default/files/2024-06/NCPA-PBMpolling_June2024.pdf

bottom of page